From Oncology to Cardiology: Expanding Clinical Applications Boost Market Growth
The Diagnostic Radiopharmaceutical is witnessing substantial growth due to the increasing prevalence of cancer, cardiovascular diseases, neurological disorders, and other chronic illnesses that require accurate and early diagnosis. Diagnostic radiopharmaceuticals are radioactive compounds used in nuclear medicine imaging techniques such as PET (Positron Emission Tomography) and SPECT (Single...
0 Commenti
0 condivisioni
232 Views